Dana Investment Advisors, Inc. Axsome Therapeutics, Inc. Transaction History

Dana Investment Advisors, Inc.

$2.99 Billion
Q3 2024

A detailed history of Dana Investment Advisors, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 17,577 shares of AXSM stock, worth $1.59 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

17,577

Previous 19,724 10.89%

Holding current value

$1.59 Million

Previous $1.59 Million 0.5%

% of portfolio

0.05%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$78.93 - $95.84 $169,462 - $205,768	-2,147 Reduced 10.89%	17,577 $1.58 Million
Q2 2024 Aug 13, 2024	BUY	$65.72 - $80.5 $45,806 - $56,108	697 Added 3.66%	19,724 $1.59 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $373,734 - $525,889	5,386 Added 39.48%	19,027 $1.52 Million
Q4 2023 Feb 07, 2024	SELL	$57.42 - $83.61 $29,111 - $42,390	-507 Reduced 3.58%	13,641 $1.09 Million
Q3 2023 Nov 15, 2023	SELL	$69.25 - $82.21 $240,159 - $285,104	-3,468 Reduced 19.69%	14,148 $988,000
Q2 2023 Aug 15, 2023	SELL	$58.41 - $90.35 $71,844 - $111,130	-1,230 Reduced 6.53%	17,616 $1.27 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $4,671 - $6,000	-80 Reduced 0.42%	18,846 $1.16 Million
Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $162,196 - $323,742	4,061 Added 27.32%	18,926 $1.46 Million
Q3 2022 Nov 15, 2022	SELL	$36.06 - $69.85 $94,080 - $182,238	-2,609 Reduced 14.93%	14,865 $663,000
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $31,914 - $68,629	1,468 Added 9.17%	17,474 $669,000
Q1 2022 May 12, 2022	SELL	$23.7 - $41.39 $85,628 - $149,542	-3,613 Reduced 18.42%	16,006 $662,000
Q4 2021 Feb 09, 2022	SELL	$30.7 - $43.36 $330,209 - $466,380	-10,756 Reduced 35.41%	19,619 $741,000
Q3 2021 Nov 12, 2021	BUY	$19.91 - $68.26 $209,592 - $718,573	10,527 Added 53.04%	30,375 $1 Million
Q2 2021 Aug 10, 2021	BUY	$50.63 - $73.5 $76,248 - $110,691	1,506 Added 8.21%	19,848 $1.34 Million
Q1 2021 May 13, 2021	BUY	$55.91 - $81.44 $1.03 Million - $1.49 Million	18,342 New	18,342 $1.04 Million

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.

Account

Dana Investment Advisors, Inc. Axsome Therapeutics, Inc. Transaction History